Orion Portfolio Solutions LLC Has $1.97 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Orion Portfolio Solutions LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,559 shares of the company’s stock after selling 176 shares during the period. Orion Portfolio Solutions LLC’s holdings in HCA Healthcare were worth $1,969,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in HCA. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at about $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $36,000. Legacy Investment Solutions LLC bought a new position in HCA Healthcare during the 3rd quarter worth about $39,000. Activest Wealth Management lifted its holdings in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its holdings in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $347.48 on Thursday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $85.55 billion, a P/E ratio of 15.82, a PEG ratio of 1.10 and a beta of 1.68. The stock has a 50 day simple moving average of $326.35 and a 200 day simple moving average of $340.30. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business posted $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date was Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is 13.11%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on HCA. Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Truist Financial lowered their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Finally, Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.